David VanThiel

1.9k total citations · 1 hit paper
9 papers, 1.6k citations indexed

About

David VanThiel is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, David VanThiel has authored 9 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Rheumatology. Recurrent topics in David VanThiel's work include Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). David VanThiel is often cited by papers focused on Hepatitis C virus research (5 papers), Liver Disease Diagnosis and Treatment (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). David VanThiel collaborates with scholars based in United States. David VanThiel's co-authors include Luis A. Balart, Henry C. Bodenheimer, Alexandra L. Gibas, John A. Payne, Terryl J. Ortego, William D. Carey, Gary L. Davis, Jules L. Dienstag, Janice K. Albrecht and Ira M. Jacobson and has published in prestigious journals such as New England Journal of Medicine, Hepatology and The FASEB Journal.

In The Last Decade

David VanThiel

9 papers receiving 1.5k citations

Hit Papers

Treatment of Chronic Hepatitis C with Recombinant Interfe... 1989 2026 2001 2013 1989 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David VanThiel United States 7 1.3k 1.1k 350 88 69 9 1.6k
Miharu Hirakawa Japan 20 1.1k 0.8× 922 0.8× 141 0.4× 49 0.6× 74 1.1× 42 1.2k
Bárbara Torres Italy 13 1.1k 0.9× 1.0k 0.9× 262 0.7× 85 1.0× 91 1.3× 37 1.6k
Ming‐Yen Hsieh Taiwan 23 1.8k 1.4× 1.8k 1.7× 159 0.5× 69 0.8× 45 0.7× 112 2.2k
Guido Colloredo Italy 17 1.5k 1.2× 1.6k 1.5× 104 0.3× 35 0.4× 32 0.5× 36 1.9k
Ziad Younes United States 22 882 0.7× 1.3k 1.2× 83 0.2× 130 1.5× 97 1.4× 67 1.8k
John Crowe Ireland 18 918 0.7× 815 0.7× 85 0.2× 125 1.4× 47 0.7× 39 1.5k
Harlan I. Wright United States 17 856 0.7× 766 0.7× 78 0.2× 97 1.1× 72 1.0× 24 1.4k
Minneke J. Coenraad Netherlands 20 877 0.7× 819 0.7× 52 0.1× 78 0.9× 193 2.8× 78 1.4k
Claudio Puoti Italy 17 946 0.7× 840 0.8× 66 0.2× 29 0.3× 51 0.7× 40 1.1k
Richard Taubert Germany 24 924 0.7× 609 0.5× 129 0.4× 405 4.6× 42 0.6× 77 1.7k

Countries citing papers authored by David VanThiel

Since Specialization
Citations

This map shows the geographic impact of David VanThiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David VanThiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David VanThiel more than expected).

Fields of papers citing papers by David VanThiel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David VanThiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David VanThiel. The network helps show where David VanThiel may publish in the future.

Co-authorship network of co-authors of David VanThiel

This figure shows the co-authorship network connecting the top 25 collaborators of David VanThiel. A scholar is included among the top collaborators of David VanThiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David VanThiel. David VanThiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kanwal, Fasiha, Alex S. Befeler, Ravi S. Chari, et al.. (2012). Potentially curative treatment in patients with hepatocellular cancer—results from the liver cancer research network. Alimentary Pharmacology & Therapeutics. 36(3). 257–265. 41 indexed citations
2.
Dhillon, Sonu, et al.. (2010). Irreversible Pulmonary Hypertension Associated with the use of Interferon Alpha for Chronic Hepatitis C. Digestive Diseases and Sciences. 55(6). 1785–1790. 55 indexed citations
4.
Alvarez, Walter C., et al.. (2003). 1013 Interferon treatment outcomes in patients with decompensated HCV + cirrhosis. Hepatology. 38. 644–645. 2 indexed citations
5.
VanThiel, David, et al.. (2003). MARKEDLY ELEVATED ALPHA FETO PROTEIN LEVELS WITHOUT HEPATOCELLULAR CARCINOMA. The American Journal of Gastroenterology. 98(60). S138–S138. 11 indexed citations
6.
Davis, Gary L., Luis A. Balart, Eugene R. Schiff, et al.. (1989). Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa. New England Journal of Medicine. 321(22). 1501–1506. 1368 indexed citations breakdown →
7.
Demetris, A.J., et al.. (1987). Double immunoenzyme staining method for analysis of tissue and blood lymphocyte subsets with monoclonal antibodies.. PubMed. 56(1). 114–9. 29 indexed citations
8.
Fisher, Stanley E., Mark Atkinson, Stanley Jacobson, et al.. (1983). Selective Fetal Malnutrition: the Effect of in Vivo Ethanol Exposure upon in Vitro Placental Uptake of Amino Acids in the Non-Human Primate. Pediatric Research. 17(9). 704–707. 27 indexed citations
9.
Cobb, Charles F., Judith S. Gavaler, & David VanThiel. (1981). Is Ethanol a Testicular Toxin?. Clinical toxicology. 18(2). 149–154. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026